Compound Chinese medicine for treating endometriosis dyspareunia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of compound Chinese medicine and endometrium, which is applied in non-central analgesics, diseases, antipyretics, etc., can solve the problems of large side effects, long course of treatment, and high recurrence rate of surgery, and achieve small side effects, willingness to accept, curative effect
Inactive Publication Date: 2012-07-04
冯冬兰 +1
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Non-symptomatic treatment is slow to take effect and has a long course of treatment, which makes it difficult for patients to adhere to it. In addition, long-term use of western medicine has serious side effects and high recurrence rate of surgery. The complications of surgery are not acceptable to patients. Factors, patients are eager for a convenient, effective and fast treatment method
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0008] Embodiment 1. a kind of Chinese medicine compound prescription for the treatment of dyspareunia, comprises the raw material of following weight composition:
[0010] Embodiment 2. a kind of Chinese medicine compound prescription for the treatment of dyspareunia, comprises the raw material of following weight composition:
[0012] Embodiment 3. a kind of Chinese medicine compound prescription for the treatment of dyspareunia, comprises the raw material of following weight composition:
[0014] The Chinese medicine compound of above several ratios is all made into capsule by above-mentioned processing procedure. It has the effects of absorbing moisture and drying dampness, clearing away heat and expelling toxins, removing blood stasis and eliminating symptoms, reducing swelling and dissipating stagnation, and relieving pain. It has a good effect on treating endometriosis and dyspareunia.
[0015] Clinical Application Overview
[0016] Efficacy criteria: cured: all symptoms disappeared, pelvic nodules and other local signs basically disappeared; markedly effective:...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a compound Chinese medicine for treating endometriosis dyspareunia in the technical field of Chinese medicines. The compound Chinese medicine consists of the following components by weight: 30 to 60 grams of golden thread, 30 to 60 grams of phellodendron, 30 to 60 grams of baical skullcap root, 30 to 60 grams of cape jasmine fruit, 60 to 600 grams of alum, 6 to 15 grams of realgar, 4 to 8 grams of common cnidium fruit, 7 to 15 grams of frankincense, 7 to 15 grams of myrrh, 1 to 3 grams of musk, 1 to 12 grams of borneol, 1 to 1.5 grams of borax, 1 to 3 grams of sal ammoniac, 10 to 20 grams of stalactite and 8 to 25 grams of dragon's blood. According to a Chinese medicinal formula, the compound Chinese medicine for treating the endometriosis dyspareunia has the effects of drying dampness, clearing heat, absorbing moisture, drawing out pus, removing stasis, eliminating diseases, relieving swelling, eliminating stagnation and relieving pain, and is suitable for dyspareunia caused by ectopia of endometria to parts such as excavatio rectouterina, uterosacral ligaments, lower sections of posterior uterine walls or vaginal fornix and the like regardless of the cause of blood stasis.
Description
technical field [0001] The invention relates to a drug preparation for the posterior vaginal fornix for treating gynecological diseases in the technical field of traditional Chinese medicine, in particular to a compound traditional Chinese medicine for treating endometriosis and dyspareunia. Background technique [0002] Endometriosis refers to a disease that occurs when endometrial tissue with growth function is implanted in other parts than the uterine body cavity. It is a common and difficult disease in gynecology, and its incidence has been on the rise in recent years. Intima can be implanted in many parts of the body, and the clinical symptoms vary with different implant sites. Pain during sexual intercourse often occurs when ectopic endometrium is implanted in the rectouterine depression, uterosacral ligament, lower segment of the posterior uterine wall, or vaginal vault, and these ectopic endometrium will periodically bleed with changes in ovarian hormones. The surro...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more